Tower Wealth Partners, Inc.

Position in NVS — Novartis AG

CIK 1852808 LEWISBURG, PA

Position in NVS

as of Jun 30, 2026 · filed Aug 12, 2026 Compact

Position Value

$343,530

+$9,008 QoQ

Shares Held

2,192

+0.1% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.74%

of 13F equity value

Holder Rank

#1,060

of 1,603 holders

Holding Since

Sep 2025

4 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Tower Wealth Partners, Inc. holds $2,793,120 across 6 Drug Manufacturers - General names. NVS ranks #5 (12.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	JNJ	Johnson & Johnson	2,818	$715,687
2	MRK	Merck & Co., Inc.	4,683	$601,765
3	AMGN	Amgen Inc	1,333	$482,705
4	ABBV	AbbVie Inc.	1,770	$445,402
5	NVS	Novartis AG This page	2,192	$343,530
6	AZN	Astrazeneca PLC	1,076	$204,031

4 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$343,530	2,192	+0.1%	Shares	Sole	2026-08-12
2026-03-31	$334,522	2,190	+8.5%	Shares	Sole	2026-05-08
2025-12-31	$278,221	2,018	+7.8%	Shares	Sole	2026-01-16
2025-09-30	$240,065	1,872	—	Shares	Sole	2025-11-07
No filing history on record for this holder in this stock.